STOCKHOLM, June 28, 2023 /PRNewswire/ -- Moberg Pharma AB (OMX: MOB) hereby announces that the Decentralized Procedure has ended with a positive outcome and that MOB-015 is recommended for national ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results